Adjuvant Approaches to Treating HER2+ Breast Cancer

Dr Tolaney on Standard Frontline Treatment Approaches in HER2+ Breast CancerПодробнее

Dr Nanda on Treatment De-Escalation in HER2+ Breast Cancer and TNBCПодробнее

Adjuvant Therapy | 2023 Best of Breast ConferenceПодробнее

Optimizing treatment in patients with early-stage HER2-positive breast cancerПодробнее

Adjuvant and Neoadjuvant Therapies for Local Advanced HER-2 Breast Cancer.Подробнее

Neoadjuvant treatment approach for HER2 positive breast cancerПодробнее

Educational Sessions: "Approving new therapies for early breast cancer"Подробнее

How to treat HER2 positive BREAST CANCER? The 2023 approach by Dr Loay KASSEMПодробнее

Neoadjuvant chemotherapy for breast cancer - Time to rethink. 27Jul22Подробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Session 10: Adjuvant treatment in patients with HER2 positive breast cancer: Risk stratification...Подробнее

Case 1: Treatment for Early-Stage HER2+ Breast CancerПодробнее

Case 1: Adjuvant Therapy for Residual Disease in HER2+ Breast CancerПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

Neoadjuvant and Adjuvant Therapy for HER2-positive Breast CancerПодробнее

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

Treatment for High- and Low-Risk HER2+ Breast CancerПодробнее

Dr. Tolaney on Novel Approaches in Treating HER2-Positive Breast CancerПодробнее

Management of axilla after neo-adjuvant treatmentПодробнее

Breast Cancer Management in North Carolina: Updates for 2021 - Y. Abdou - 20210623Подробнее